NCT06019923Recruiting
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 17 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Ovarian cancer is a highly lethal gynecological malignancy, often diagnosed at an advanced stage, with high rates of recurrence within 1-2 years after frontline treatment. Current guidelines recommend monitoring tumor markers CA125 and HE4 for disease progression, but these markers may not detect recurrence or disease progression when their levels are below the detection limit. Therefore, there is a need to identify new prognostic biomarkers and monitor their dynamic changes for effective risk stratification and personalized treatment in patients with ovarian cancer
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 24 Aug 2023
- Start date
- 26 Oct 2023
- Primary completion date
- 10 Sept 2026
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Diseases
- Ovarian cancer
- NCT number
- NCT06019923
What you commit to
- Study type: Observational
- Planned participants: 100
- From 26 Oct 2023 to the primary completion date, 10 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Ovarian cancer patients who have not undergone surgical treatment;
- Patients with a history of other malignancies.
Other
- Non-primary (recurrent) patients;
Who the study is looking for
- Age between 18 and 75 years;
- Pathological diagnosis of high-grade serous ovarian cancer;
- Newly diagnosed ovarian cancer case without prior neoadjuvant therapy.
Age in the registry: 18 years to 75 years · Sex: Female
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Women's hospital school of medicine Zhejiang University Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.